Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelika Roth

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Molecular Microbiology and Biotechnology|December 11, 2012
The capsule of Streptococcus pneumoniae contributes to virulence in the insect model Manduca sextaAngelika Roth, Peter Reichmann, Regine Hakenbeck
Solid State Nuclear Magnetic Resonance|December 14, 2004
The role of carbon in the nitridic high performance ceramics in the system Si-B-N-CLeo van Wüllen, Angelika Roth, Martin Jansen
Current Medical Research and Opinion|August 22, 2008
Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjectsDagmar Kubitza, Michael Becka, Angelika Roth, et al.
Journal of Clinical Pharmacology|February 6, 2013
The influence of age and gender on the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct Factor Xa inhibitorDagmar Kubitza, Michael Becka, Angelika Roth, et al.
Clinical Chemistry and Laboratory Medicine|August 7, 2008
Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers - comparison of ELISA and microsphere-based multiplexed immunoassayMartin Kornacker, Angelika Roth, Olaf Christensen, et al.
British Journal of Clinical Pharmacology|January 9, 2013
Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitorDagmar Kubitza, Angelika Roth, Michael Becka, et al.
Molecular Nutrition & Food Research|March 14, 2013
Opinion on the use of plasma processes for treatment of foodsOliver Schlüter, Jörg Ehlbeck, Christian Hertel, et al.
Critical Reviews in Toxicology|August 16, 2024
Dietary glycation compounds - implications for human healthMichael Hellwig, Patrick Diel, Gerhard Eisenbrand, et al.
Nutrients|February 13, 2025
Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health ClaimsBarbara E Engeli, Dirk W Lachenmeier, Patrick Diel, et al.
FEMS Microbiology Reviews|January 20, 2026
Limitations and safety aspects related to the use of bacteriophages in food productionAngelika Roth, Charles M A P Franz, Stefan Hertwig, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Molecular Microbiology and Biotechnology|December 11, 2012
The capsule of Streptococcus pneumoniae contributes to virulence in the insect model Manduca sextaAngelika Roth, Peter Reichmann, Regine Hakenbeck
Solid State Nuclear Magnetic Resonance|December 14, 2004
The role of carbon in the nitridic high performance ceramics in the system Si-B-N-CLeo van Wüllen, Angelika Roth, Martin Jansen
Current Medical Research and Opinion|August 22, 2008
Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjectsDagmar Kubitza, Michael Becka, Angelika Roth, et al.
Journal of Clinical Pharmacology|February 6, 2013
The influence of age and gender on the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct Factor Xa inhibitorDagmar Kubitza, Michael Becka, Angelika Roth, et al.
Clinical Chemistry and Laboratory Medicine|August 7, 2008
Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers - comparison of ELISA and microsphere-based multiplexed immunoassayMartin Kornacker, Angelika Roth, Olaf Christensen, et al.
British Journal of Clinical Pharmacology|January 9, 2013
Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitorDagmar Kubitza, Angelika Roth, Michael Becka, et al.
Molecular Nutrition & Food Research|March 14, 2013
Opinion on the use of plasma processes for treatment of foodsOliver Schlüter, Jörg Ehlbeck, Christian Hertel, et al.
Critical Reviews in Toxicology|August 16, 2024
Dietary glycation compounds - implications for human healthMichael Hellwig, Patrick Diel, Gerhard Eisenbrand, et al.
Nutrients|February 13, 2025
Cannabidiol in Foods and Food Supplements: Evaluation of Health Risks and Health ClaimsBarbara E Engeli, Dirk W Lachenmeier, Patrick Diel, et al.
FEMS Microbiology Reviews|January 20, 2026
Limitations and safety aspects related to the use of bacteriophages in food productionAngelika Roth, Charles M A P Franz, Stefan Hertwig, et al.
Pageof 2